Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	Urease Treatment	Volume Urine (µL)	Gender	Solution Added	Ethnicity
MS positive ion mode	pseudouridine	4932969.209	Peak area	Urease pre-treatment	5	N/A	N/A	N/A
MS positive ion mode	pseudouridine	5386811.371	Peak area	Urease pre-treatment	5	N/A	N/A	N/A
MS positive ion mode	pseudouridine	5484974.918	Peak area	No treatment	5	N/A	N/A	N/A
MS positive ion mode	pseudouridine	5593681.104	Peak area	Urease pre-treatment	5	N/A	N/A	N/A
MS positive ion mode	pseudouridine	5739700.71	Peak area	No treatment	5	N/A	N/A	N/A
MS positive ion mode	pseudouridine	6411250.446	Peak area	No treatment	5	N/A	N/A	N/A
MS positive ion mode	pseudouridine	9209129.486	Peak area	No treatment	50	Male	N/A	Hispanic
MS positive ion mode	pseudouridine	9344000.8	Peak area	No treatment	50	Male	N/A	Hispanic
MS positive ion mode	pseudouridine	10345922.29	Peak area	Urease pre-treatment	50	Male	N/A	Hispanic
MS positive ion mode	pseudouridine	10494911.64	Peak area	No treatment	10	N/A	N/A	N/A
MS positive ion mode	pseudouridine	10606596.6	Peak area	Urease pre-treatment	10	N/A	N/A	N/A
MS positive ion mode	pseudouridine	10720476.25	Peak area	Urease pre-treatment	10	N/A	N/A	N/A
MS positive ion mode	pseudouridine	10793553.71	Peak area	Urease pre-treatment	10	N/A	N/A	N/A
MS positive ion mode	pseudouridine	11036691.27	Peak area	No treatment	10	N/A	N/A	N/A
MS positive ion mode	pseudouridine	11554376.11	Peak area	Urease pre-treatment	50	Male	N/A	Hispanic
MS positive ion mode	pseudouridine	11594163.6	Peak area	No treatment	10	N/A	N/A	N/A
MS positive ion mode	pseudouridine	11693517.09	Peak area	No treatment	50	Female	N/A	Hispanic
MS positive ion mode	pseudouridine	12684921.31	Peak area	Urease pre-treatment	50	Female	N/A	Hispanic
MS positive ion mode	pseudouridine	14857122.91	Peak area	Urease pre-treatment	50	Female	N/A	Hispanic
MS positive ion mode	pseudouridine	15452266.43	Peak area	No treatment	50	Female	N/A	Hispanic
MS positive ion mode	pseudouridine	15964937	Peak area	Urease pre-treatment	50	Female	N/A	Hispanic
MS positive ion mode	pseudouridine	17106903.71	Peak area	Urease pre-treatment	50	Female	N/A	Hispanic
MS positive ion mode	pseudouridine	19096850.31	Peak area	No treatment	50	Female	N/A	Hispanic
MS positive ion mode	pseudouridine	19387706.2	Peak area	No treatment	50	Female	N/A	Hispanic
MS positive ion mode	pseudouridine	20286477.71	Peak area	No treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	21076179.66	Peak area	Urease pre-treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	23925729.09	Peak area	Urease pre-treatment	50	Female	N/A	Hispanic
MS positive ion mode	pseudouridine	24904943.09	Peak area	Urease pre-treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	25007454.17	Peak area	Urease pre-treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	25152581.89	Peak area	Urease pre-treatment	25	N/A	N/A	N/A
MS positive ion mode	pseudouridine	25399570.51	Peak area	Urease pre-treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	25718802.51	Peak area	Urease pre-treatment	50	Male	N/A	Hispanic
MS positive ion mode	pseudouridine	26365737.66	Peak area	No treatment	25	N/A	N/A	N/A
MS positive ion mode	pseudouridine	26385573	Peak area	Urease pre-treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	26787175.7	Peak area	Urease pre-treatment	25	N/A	N/A	N/A
MS positive ion mode	pseudouridine	27531409	Peak area	Urease pre-treatment	25	N/A	N/A	N/A
MS positive ion mode	pseudouridine	27648441.02	Peak area	No treatment	25	N/A	N/A	N/A
MS positive ion mode	pseudouridine	28561416.11	Peak area	No treatment	25	N/A	N/A	N/A
MS positive ion mode	pseudouridine	29759086.09	Peak area	Urease pre-treatment	50	Female	N/A	Hispanic
MS positive ion mode	pseudouridine	32142446.66	Peak area	No treatment	50	Male	N/A	Hispanic
MS positive ion mode	pseudouridine	32993237.83	Peak area	No treatment	50	Female	N/A	Hispanic
MS positive ion mode	pseudouridine	38691384.4	Peak area	No treatment	50	Female	N/A	Hispanic
MS positive ion mode	pseudouridine	39327660.74	Peak area	No treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	39488969.14	Peak area	No treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	40002195	Peak area	No treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	40328305.14	Peak area	No treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	40623713.86	Peak area	Urease pre-treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	40811379.2	Peak area	No treatment	50	Male	N/A	Hispanic
MS positive ion mode	pseudouridine	41209748.57	Peak area	Urease pre-treatment	50	Female	N/A	Black
MS positive ion mode	pseudouridine	41279000.69	Peak area	Urease pre-treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	42147626.06	Peak area	No treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	42656595.89	Peak area	No treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	43022672.91	Peak area	Urease pre-treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	43451006.86	Peak area	No treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	43627392.14	Peak area	No treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	43896104	Peak area	Urease pre-treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	45062881.14	Peak area	No treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	45359688.69	Peak area	Urease pre-treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	46518351.46	Peak area	No treatment	50	Female	N/A	Asian
MS positive ion mode	pseudouridine	47069075.91	Peak area	Urease pre-treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	47076781.31	Peak area	Urease pre-treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	47201452.71	Peak area	No treatment	50	Male	N/A	Hispanic
MS positive ion mode	pseudouridine	47599875.2	Peak area	No treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	47940418.51	Peak area	No treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	48106648.89	Peak area	No treatment	50	Male	N/A	Hispanic
MS positive ion mode	pseudouridine	48157677.51	Peak area	Urease pre-treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	48163693.49	Peak area	Urease pre-treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	48297268.57	Peak area	Urease pre-treatment	50	Male	N/A	Hispanic
MS positive ion mode	pseudouridine	49160116.77	Peak area	Urease pre-treatment	50	Male	N/A	Hispanic
MS positive ion mode	pseudouridine	49966555.62	Peak area	No treatment	50	N/A	N/A	N/A
MS positive ion mode	pseudouridine	50104402.46	Peak area	No treatment	50	Female	N/A	Asian
MS positive ion mode	pseudouridine	50406255.74	Peak area	No treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	50586154.23	Peak area	Urease pre-treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	51050298.55	Peak area	Urease pre-treatment	50	N/A	N/A	N/A
MS positive ion mode	pseudouridine	51078228.86	Peak area	No treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	51085084.34	Peak area	Urease pre-treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	51171989.25	Peak area	Urease pre-treatment	50	N/A	N/A	N/A
MS positive ion mode	pseudouridine	51479187.66	Peak area	No treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	51580139.89	Peak area	Urease pre-treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	52304435.71	Peak area	No treatment	50	Male	N/A	Hispanic
MS positive ion mode	pseudouridine	52521284.73	Peak area	No treatment	50	N/A	N/A	N/A
MS positive ion mode	pseudouridine	52573750.51	Peak area	Urease pre-treatment	50	Female	N/A	Asian
MS positive ion mode	pseudouridine	52696285.71	Peak area	Urease pre-treatment	50	Male	N/A	Hispanic
MS positive ion mode	pseudouridine	52790476.32	Peak area	Urease pre-treatment	50	N/A	N/A	N/A
MS positive ion mode	pseudouridine	53131640.51	Peak area	Urease pre-treatment	50	Female	N/A	Asian
MS positive ion mode	pseudouridine	53180039.31	Peak area	Urease pre-treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	53194471.77	Peak area	Urease pre-treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	53636071.4	Peak area	No treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	53786202.49	Peak area	Urease pre-treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	54478827.2	Peak area	Urease pre-treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	54619127.39	Peak area	No treatment	50	N/A	N/A	N/A
MS positive ion mode	pseudouridine	54754444.57	Peak area	Urease pre-treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	55130596.03	Peak area	No treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	55351613.8	Peak area	No treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	55446345.57	Peak area	No treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	55474400.46	Peak area	Urease pre-treatment	50	Male	N/A	Hispanic
MS positive ion mode	pseudouridine	55684815.4	Peak area	No treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	55748084.2	Peak area	No treatment	50	Male	N/A	Hispanic
MS positive ion mode	pseudouridine	56765282.23	Peak area	Urease pre-treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	57688100.11	Peak area	No treatment	50	Male	N/A	Hispanic
MS positive ion mode	pseudouridine	57805277.71	Peak area	Urease pre-treatment	50	Male	N/A	Hispanic
MS positive ion mode	pseudouridine	57856975.6	Peak area	No treatment	50	Female	N/A	Black
MS positive ion mode	pseudouridine	59748831.34	Peak area	Urease pre-treatment	50	Male	N/A	Hispanic
MS positive ion mode	pseudouridine	59761778.6	Peak area	Urease pre-treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	60152782.34	Peak area	No treatment	50	Male	N/A	Hispanic
MS positive ion mode	pseudouridine	60224914.29	Peak area	Urease pre-treatment	50	Male	N/A	Hispanic
MS positive ion mode	pseudouridine	60257772	Peak area	Urease pre-treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	60316949.26	Peak area	No treatment	50	Male	N/A	Hispanic
MS positive ion mode	pseudouridine	60559070.57	Peak area	No treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	61321191.29	Peak area	Urease pre-treatment	50	Female	N/A	Hispanic
MS positive ion mode	pseudouridine	61742875.89	Peak area	Urease pre-treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	62154702.57	Peak area	No treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	63635642.74	Peak area	Urease pre-treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	63772099.2	Peak area	Urease pre-treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	64647851.51	Peak area	No treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	64707991.83	Peak area	No treatment	50	Female	N/A	Black
MS positive ion mode	pseudouridine	65095906.51	Peak area	No treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	65720558.4	Peak area	No treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	65951677.26	Peak area	Urease pre-treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	66023365.14	Peak area	Urease pre-treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	67696933.66	Peak area	Urease pre-treatment	50	Male	N/A	Hispanic
MS positive ion mode	pseudouridine	67855290	Peak area	No treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	68218897.14	Peak area	Urease pre-treatment	50	Male	N/A	Hispanic
MS positive ion mode	pseudouridine	68372042.06	Peak area	Urease pre-treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	69991107.43	Peak area	No treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	70012221.29	Peak area	No treatment	100	N/A	N/A	N/A
MS positive ion mode	pseudouridine	70123828.11	Peak area	No treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	70554682.97	Peak area	Urease pre-treatment	50	Male	N/A	Hispanic
MS positive ion mode	pseudouridine	71603341.03	Peak area	No treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	71688875.89	Peak area	Urease pre-treatment	50	Female	N/A	Black
MS positive ion mode	pseudouridine	71750048.77	Peak area	No treatment	50	Female	N/A	Hispanic
MS positive ion mode	pseudouridine	71853409.37	Peak area	Urease pre-treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	71955513.97	Peak area	Urease pre-treatment	50	Male	N/A	Hispanic
MS positive ion mode	pseudouridine	72096526.8	Peak area	No treatment	50	Male	N/A	Hispanic
MS positive ion mode	pseudouridine	72199091.37	Peak area	No treatment	50	Female	N/A	Hispanic
MS positive ion mode	pseudouridine	72518075.89	Peak area	Urease pre-treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	72759356.11	Peak area	No treatment	50	Male	N/A	Hispanic
MS positive ion mode	pseudouridine	72804341.49	Peak area	Urease pre-treatment	50	Male	N/A	Hispanic
MS positive ion mode	pseudouridine	73139988.57	Peak area	Urease pre-treatment	50	Female	N/A	Hispanic
MS positive ion mode	pseudouridine	73535544.91	Peak area	No treatment	50	Male	N/A	Hispanic
MS positive ion mode	pseudouridine	74041349.49	Peak area	No treatment	50	Female	N/A	Black
MS positive ion mode	pseudouridine	74406518.86	Peak area	No treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	74565521.91	Peak area	No treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	75299647.29	Peak area	No treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	75487413.94	Peak area	No treatment	50	Female	N/A	Black
MS positive ion mode	pseudouridine	75515052.8	Peak area	Urease pre-treatment	50	Female	N/A	Black
MS positive ion mode	pseudouridine	75728972.8	Peak area	No treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	76079584	Peak area	Urease pre-treatment	50	Female	N/A	Asian
MS positive ion mode	pseudouridine	77014787.34	Peak area	No treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	77866906.4	Peak area	No treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	78548645.94	Peak area	No treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	79345119.54	Peak area	Urease pre-treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	80027298.74	Peak area	Urease pre-treatment	50	Female	N/A	Asian
MS positive ion mode	pseudouridine	80892078.63	Peak area	Urease pre-treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	81654595.77	Peak area	Urease pre-treatment	50	Male	N/A	Hispanic
MS positive ion mode	pseudouridine	81731111.31	Peak area	Urease pre-treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	81873938.29	Peak area	No treatment	50	Male	N/A	Hispanic
MS positive ion mode	pseudouridine	82516710.86	Peak area	No treatment	50	Female	N/A	Asian
MS positive ion mode	pseudouridine	82575101.2	Peak area	No treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	82853247.94	Peak area	Urease pre-treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	83706490.51	Peak area	No treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	83723018.74	Peak area	No treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	83810696.23	Peak area	Urease pre-treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	83976472.23	Peak area	Urease pre-treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	84272733.94	Peak area	Urease pre-treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	84761675.43	Peak area	No treatment	50	Male	N/A	Hispanic
MS positive ion mode	pseudouridine	85166498.74	Peak area	No treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	85362905.47	Peak area	No treatment	100	N/A	N/A	N/A
MS positive ion mode	pseudouridine	85410375.77	Peak area	No treatment	50	Male	N/A	Hispanic
MS positive ion mode	pseudouridine	85543709.26	Peak area	Urease pre-treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	86326244.57	Peak area	Urease pre-treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	86351547.9	Peak area	No treatment	100	N/A	N/A	N/A
MS positive ion mode	pseudouridine	86648581.49	Peak area	Urease pre-treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	86750935.77	Peak area	Urease pre-treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	87152970.51	Peak area	Urease pre-treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	89036669.26	Peak area	No treatment	50	Female	N/A	Asian
MS positive ion mode	pseudouridine	89283104	Peak area	No treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	89490717.71	Peak area	No treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	90167666.74	Peak area	No treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	90881549.71	Peak area	No treatment	50	Male	N/A	Caucasian
MS positive ion mode	pseudouridine	91268895.54	Peak area	No treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	91813213.71	Peak area	Urease pre-treatment	50	Male	N/A	Hispanic
MS positive ion mode	pseudouridine	94688962.64	Peak area	Urease pre-treatment	100	N/A	N/A	N/A
MS positive ion mode	pseudouridine	94704903.31	Peak area	Urease pre-treatment	50	Female	N/A	Black
MS positive ion mode	pseudouridine	95165604.51	Peak area	Urease pre-treatment	100	N/A	N/A	N/A
MS positive ion mode	pseudouridine	95914608.91	Peak area	No treatment	50	Female	N/A	Caucasian
MS positive ion mode	pseudouridine	96476099.66	Peak area	Urease pre-treatment	50	Male	N/A	Hispanic
MS positive ion mode	pseudouridine	96795160.91	Peak area	No treatment	50	Male	N/A	Hispanic
MS positive ion mode	pseudouridine	99498378.27	Peak area	Urease pre-treatment	100	N/A	N/A	N/A
MS positive ion mode	pseudouridine	105060605.3	Peak area	Urease pre-treatment	50	Male	N/A	Caucasian